Daniele Pastori

Pubblicazioni

Titolo Pubblicato in Anno
Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study MOLECULES 2021
Stroke Care during the COVID-19 Pandemic: International Expert Panel Review CEREBROVASCULAR DISEASES 2021
Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-Register BLOOD TRANSFUSION 2021
Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review and meta-analysis AUTOIMMUNITY REVIEWS 2021
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome INTERNAL AND EMERGENCY MEDICINE 2021
The role of antioxidants supplementation in clinical practice: focus on cardiovascular risk factors ANTIOXIDANTS 2021
Time to hospitalisation, CT pulmonary involvement and in-hospital death in COVID-19 patients in an Emergency Medicine Unit INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 2021
Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes JOURNAL OF CARDIOLOGY 2021
Cancer and atrial fibrillation. epidemiology, mechanisms, and anticoagulation treatment PROGRESS IN CARDIOVASCULAR DISEASES 2021
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus FRONTIERS IN PHARMACOLOGY 2021
Low serum albumin levels and in-hospital outcomes in patients with ST segment elevation myocardial infarction NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2021
Risk scores for death in patients with cancer-related venous thromboembolism. still a long road ahead THROMBOSIS AND HAEMOSTASIS 2021
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd). A multicenter observational study NUTRIENTS 2021
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Open issues in the transition from nafld to mafld. the experience of the plinio study INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2021
The challenge of cardiovascular prevention in NAFLD THE LANCET. GASTROENTEROLOGY & HEPATOLOGY 2021
Antiphospholipid antibodies and heart failure with preserved ejection fraction. The multicenter ATHERO-APS study JOURNAL OF CLINICAL MEDICINE 2021
D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients. asystematic review and metanalysis THROMBOSIS JOURNAL 2021
Oxidative stress in the pathogenesis of antiphospholipid syndrome. Implications for the atherothrombotic process ANTIOXIDANTS 2021
A systematic review and a meta-analysis comparing prophylactic and therapeutic low molecular weight heparins for mortality reduction in 32,688 COVID-19 patients FRONTIERS IN PHARMACOLOGY 2021

ERC

  • LS4
  • LS4_10
  • LS7
  • LS7_10

Keywords

cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma